Envoy Medical, Inc.
corporate_fare Company Profile
Envoy Medical, Inc. (NASDAQ:COCH) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 34 items for COCH at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-05, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 11 rated 8 or above. Recent SEC coverage for COCH spans 8-K, DEF 14A, PRE 14A, 10-Q.
Recent high-impact activity:
- Envoy Medical Beats Q3 Loss Estimates at $0.50/Share, Revenue Up 57%
- Envoy Medical Q3 Loss Narrows to $5.2M; Cash $14.6M as PMA Module Two Filed
- Envoy Medical Sets October 12 Vote on 1-for-5 to 1-for-25 Reverse Split to Avoid Nasdaq Delisting
- Envoy Medical Seeks Shareholder Approval for Reverse Stock Split to Regain Nasdaq Compliance
- Envoy Medical Reports Q2 2026 Results, Submits First PMA Module to FDA, and Posts Positive 12-Month Trial Data
Financial Snapshot
Short Interest & Short Volume
2.67 days to coverFINRA reported short interest of 89,915 shares in COCH as of the October 30, 2026 settlement, a 84.4% decrease from the prior period — about 2.7 days to cover at its recent average daily volume. On November 13, 2026, 34.2% of COCH volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.